VOLA II trial results to ‘change practice’ and ‘improve outcomes’


“We wanted to find a common language between interventional radiologists and nephrologists and we wanted to be sure that the angioplasty we have done has a functional improvement”, associate professor of interventional radiology, Stavros Spiliopoulos (Athens, Greece) speaks to Renal Interventions about the VOLA II trial, of which he was principal investigator.

VOLA II, a prospective, multicentre study of 100 arterio­venous fistula (AVF), which revealed post-procedural volume flow (VF) is an independent predictor of patency, and has been submitted for publication. Expanding on the significance of their findings, Spiliopoulos imparts: “I advise everyone to use this tool because it will change their practice and improve their outcomes”.


Please enter your comment!
Please enter your name here